Rank | Gene Set | Z-score |
---|---|---|
1 | establishment of skin barrier (GO:0061436) | 7.85157296 |
2 | regulation of water loss via skin (GO:0033561) | 6.92650206 |
3 | desmosome organization (GO:0002934) | 6.70185519 |
4 | hemidesmosome assembly (GO:0031581) | 5.01683030 |
5 | keratinization (GO:0031424) | 4.98733499 |
6 | water homeostasis (GO:0030104) | 4.53756827 |
7 | multicellular organismal water homeostasis (GO:0050891) | 4.52803661 |
8 | negative regulation of interleukin-12 production (GO:0032695) | 4.41825653 |
9 | detection of other organism (GO:0098543) | 4.41293339 |
10 | detection of bacterium (GO:0016045) | 4.34268026 |
11 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.89307320 |
12 | keratinocyte differentiation (GO:0030216) | 3.88668827 |
13 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.88488080 |
14 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.81711039 |
15 | cellular extravasation (GO:0045123) | 3.79784429 |
16 | peptide cross-linking (GO:0018149) | 3.75848615 |
17 | keratinocyte proliferation (GO:0043616) | 3.72224865 |
18 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.70856523 |
19 | detection of biotic stimulus (GO:0009595) | 3.68996484 |
20 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.66800799 |
21 | detection of external biotic stimulus (GO:0098581) | 3.64230845 |
22 | positive regulation of cholesterol efflux (GO:0010875) | 3.61833441 |
23 | phospholipid efflux (GO:0033700) | 3.61607815 |
24 | lipoxygenase pathway (GO:0019372) | 3.60820379 |
25 | immunoglobulin mediated immune response (GO:0016064) | 3.58894378 |
26 | regulation of chemokine biosynthetic process (GO:0045073) | 3.54717097 |
27 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.48345556 |
28 | positive regulation by symbiont of host defense response (GO:0052509) | 3.42666128 |
29 | modulation by symbiont of host defense response (GO:0052031) | 3.42666128 |
30 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.42666128 |
31 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.42666128 |
32 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.42666128 |
33 | modulation by symbiont of host immune response (GO:0052553) | 3.42666128 |
34 | regulation of cell proliferation involved in kidney development (GO:1901722) | 3.40913741 |
35 | regulation of phospholipase A2 activity (GO:0032429) | 3.32860496 |
36 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 3.32733529 |
37 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.31501151 |
38 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.28025528 |
39 | germinal center formation (GO:0002467) | 3.25363100 |
40 | regulation of monocyte chemotaxis (GO:0090025) | 3.24813789 |
41 | positive regulation of antigen processing and presentation (GO:0002579) | 3.24024519 |
42 | detection of molecule of bacterial origin (GO:0032490) | 3.19692207 |
43 | protein localization to endosome (GO:0036010) | 3.19419719 |
44 | positive regulation of sterol transport (GO:0032373) | 3.19395224 |
45 | positive regulation of cholesterol transport (GO:0032376) | 3.19395224 |
46 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.18100900 |
47 | neutrophil mediated immunity (GO:0002446) | 3.14952194 |
48 | NIK/NF-kappaB signaling (GO:0038061) | 3.12680141 |
49 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.10428094 |
50 | granulocyte activation (GO:0036230) | 3.09875621 |
51 | regulation of interleukin-8 secretion (GO:2000482) | 3.05836933 |
52 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.05258669 |
53 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.04661114 |
54 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.03627041 |
55 | regulation of vitamin metabolic process (GO:0030656) | 3.02732342 |
56 | surfactant homeostasis (GO:0043129) | 2.99461893 |
57 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.98473014 |
58 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.96608059 |
59 | regulation of mast cell degranulation (GO:0043304) | 2.96424623 |
60 | membrane raft organization (GO:0031579) | 2.94681507 |
61 | hair cycle (GO:0042633) | 2.94204405 |
62 | molting cycle (GO:0042303) | 2.94204405 |
63 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.93361744 |
64 | regulation of integrin activation (GO:0033623) | 2.92014688 |
65 | T-helper 1 type immune response (GO:0042088) | 2.92007352 |
66 | myeloid cell activation involved in immune response (GO:0002275) | 2.91693633 |
67 | epidermal cell differentiation (GO:0009913) | 2.91330575 |
68 | chemical homeostasis within a tissue (GO:0048875) | 2.90858526 |
69 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.87466703 |
70 | negative regulation of cell killing (GO:0031342) | 2.86519685 |
71 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.86519685 |
72 | regulation of podosome assembly (GO:0071801) | 2.86187590 |
73 | regulation of transforming growth factor beta1 production (GO:0032908) | 2.84840950 |
74 | positive regulation of type 2 immune response (GO:0002830) | 2.82830295 |
75 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.82717468 |
76 | neutrophil activation (GO:0042119) | 2.81988138 |
77 | regulation of interferon-alpha production (GO:0032647) | 2.79276586 |
78 | defense response to protozoan (GO:0042832) | 2.79057339 |
79 | positive regulation of interleukin-6 production (GO:0032755) | 2.78891540 |
80 | type I interferon signaling pathway (GO:0060337) | 2.78772866 |
81 | cellular response to type I interferon (GO:0071357) | 2.78772866 |
82 | regulation of antigen processing and presentation (GO:0002577) | 2.78594845 |
83 | regulation of natural killer cell differentiation (GO:0032823) | 2.78417879 |
84 | response to protozoan (GO:0001562) | 2.78190615 |
85 | sphingosine metabolic process (GO:0006670) | 2.77898962 |
86 | superoxide anion generation (GO:0042554) | 2.77788396 |
87 | myeloid dendritic cell differentiation (GO:0043011) | 2.77102442 |
88 | regulation of leukocyte degranulation (GO:0043300) | 2.75872308 |
89 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.74521945 |
90 | positive regulation of mast cell activation (GO:0033005) | 2.74446372 |
91 | response to type I interferon (GO:0034340) | 2.74155924 |
92 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.73221804 |
93 | mature B cell differentiation involved in immune response (GO:0002313) | 2.71803236 |
94 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.71370969 |
95 | negative regulation of growth of symbiont in host (GO:0044130) | 2.70667259 |
96 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 2.70667259 |
97 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 2.70667259 |
98 | regulation of growth of symbiont in host (GO:0044126) | 2.70667259 |
99 | positive regulation of leukocyte degranulation (GO:0043302) | 2.70341323 |
100 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.69920956 |
101 | glycosphingolipid catabolic process (GO:0046479) | 2.68712762 |
102 | leukocyte aggregation (GO:0070486) | 2.68612273 |
103 | B cell mediated immunity (GO:0019724) | 2.68185887 |
104 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 2.67838083 |
105 | negative regulation of interleukin-17 production (GO:0032700) | 2.66351544 |
106 | positive regulation of interferon-alpha production (GO:0032727) | 2.65792652 |
107 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.65617933 |
108 | neutrophil activation involved in immune response (GO:0002283) | 2.65146246 |
109 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.64034927 |
110 | long-chain fatty acid biosynthetic process (GO:0042759) | 2.63478665 |
111 | positive regulation of glomerulus development (GO:0090193) | 2.62290099 |
112 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.62177386 |
113 | regulation of interleukin-6 production (GO:0032675) | 2.62140747 |
114 | regulation of type 2 immune response (GO:0002828) | 2.61294797 |
115 | myeloid dendritic cell activation (GO:0001773) | 2.61027983 |
116 | regulation of mast cell activation (GO:0033003) | 2.60855636 |
117 | regulation of T cell tolerance induction (GO:0002664) | 2.60249903 |
118 | cellular response to lipopolysaccharide (GO:0071222) | 2.59706473 |
119 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.58671406 |
120 | regulation of tolerance induction (GO:0002643) | 2.58031889 |
121 | dendritic cell migration (GO:0036336) | 2.56620853 |
122 | cellular response to molecule of bacterial origin (GO:0071219) | 2.55721864 |
123 | sphingoid metabolic process (GO:0046519) | 2.55656996 |
124 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.55427707 |
125 | positive regulation of mast cell degranulation (GO:0043306) | 2.55427707 |
126 | microglial cell activation (GO:0001774) | 2.54791960 |
127 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.54544601 |
128 | macrophage activation involved in immune response (GO:0002281) | 2.54528255 |
129 | epidermis development (GO:0008544) | 2.54196721 |
130 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.54150118 |
131 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.53756202 |
132 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.53631846 |
133 | positive regulation of odontogenesis (GO:0042482) | 2.53341186 |
134 | eosinophil chemotaxis (GO:0048245) | 2.52522123 |
135 | response to host immune response (GO:0052572) | 2.52460697 |
136 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 2.51800140 |
137 | glucosamine-containing compound catabolic process (GO:1901072) | 2.51294161 |
138 | regulation of mononuclear cell migration (GO:0071675) | 2.50380133 |
139 | regulation of hypersensitivity (GO:0002883) | 2.49453337 |
140 | positive regulation of T-helper 1 type immune response (GO:0002827) | 2.48919127 |
141 | positive regulation of interleukin-1 secretion (GO:0050716) | 2.48173564 |
142 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.47013461 |
143 | positive regulation of granulocyte chemotaxis (GO:0071624) | 2.46382168 |
144 | positive regulation of hair cycle (GO:0042635) | 2.45415901 |
145 | positive regulation of hair follicle development (GO:0051798) | 2.45415901 |
146 | keratinocyte development (GO:0003334) | 2.44507361 |
147 | monocyte chemotaxis (GO:0002548) | 2.40596842 |
148 | response to peptidoglycan (GO:0032494) | 2.40465770 |
149 | pinocytosis (GO:0006907) | 2.39983052 |
150 | skin morphogenesis (GO:0043589) | 2.39230188 |
151 | eosinophil migration (GO:0072677) | 2.39142384 |
152 | regulation of hair follicle development (GO:0051797) | 2.37415515 |
153 | regulation of heterotypic cell-cell adhesion (GO:0034114) | 2.37326620 |
154 | fibrinolysis (GO:0042730) | 2.36838446 |
155 | regulation of interleukin-1 beta secretion (GO:0050706) | 2.36783282 |
156 | positive regulation of lymphocyte migration (GO:2000403) | 2.35099895 |
157 | diol metabolic process (GO:0034311) | 2.32877338 |
158 | positive regulation of T cell migration (GO:2000406) | 2.31434263 |
159 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.30157453 |
160 | cyclooxygenase pathway (GO:0019371) | 2.29633131 |
161 | regulation of cholesterol efflux (GO:0010874) | 2.27583993 |
162 | pericardium development (GO:0060039) | 2.27074595 |
163 | positive regulation of interleukin-8 secretion (GO:2000484) | 2.26473567 |
164 | positive regulation of interleukin-1 beta production (GO:0032731) | 2.26008263 |
165 | regulation of interleukin-1 secretion (GO:0050704) | 2.25687770 |
166 | positive regulation of chemokine secretion (GO:0090197) | 2.25624794 |
167 | respiratory burst (GO:0045730) | 2.23952427 |
168 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.23277797 |
169 | regulation of Cdc42 GTPase activity (GO:0043088) | 2.23140640 |
170 | macrophage activation (GO:0042116) | 2.22971651 |
171 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.22680494 |
172 | response to muramyl dipeptide (GO:0032495) | 2.22625392 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 8.76497970 |
2 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 4.02398751 |
3 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 3.01144639 |
4 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.94504360 |
5 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.78775545 |
6 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.46538228 |
7 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.44683193 |
8 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.41306208 |
9 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.36310769 |
10 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.35365653 |
11 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.35026872 |
12 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.31168163 |
13 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.28418302 |
14 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.24105678 |
15 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.15156981 |
16 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.14811081 |
17 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.13928822 |
18 | * SOX9_24532713_ChIP-Seq_HFSC_Mouse | 2.12423271 |
19 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 2.01978403 |
20 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.99314802 |
21 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.94533849 |
22 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.93377597 |
23 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.89027165 |
24 | SPI1_23127762_ChIP-Seq_K562_Human | 1.85584021 |
25 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.85456033 |
26 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.81044645 |
27 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.80716198 |
28 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.80173917 |
29 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.71264609 |
30 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.70662789 |
31 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.69801883 |
32 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.69498999 |
33 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.68812361 |
34 | CJUN_26792858_Chip-Seq_BT549_Human | 1.65804279 |
35 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.65733447 |
36 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.65111656 |
37 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.65088514 |
38 | MYB_26560356_Chip-Seq_TH2_Human | 1.63530257 |
39 | MAF_26560356_Chip-Seq_TH1_Human | 1.63408794 |
40 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.60470919 |
41 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.56351230 |
42 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.55986726 |
43 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.55986726 |
44 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.52082786 |
45 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.51924352 |
46 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.51537940 |
47 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.51087601 |
48 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.51087601 |
49 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.49827679 |
50 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.47592504 |
51 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.46022666 |
52 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.45157520 |
53 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.44260931 |
54 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.43952277 |
55 | RXR_22108803_ChIP-Seq_LS180_Human | 1.43775131 |
56 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.43021213 |
57 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.42924607 |
58 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.38930294 |
59 | MYB_26560356_Chip-Seq_TH1_Human | 1.38690851 |
60 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.37724406 |
61 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.35540406 |
62 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.34898048 |
63 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.34543067 |
64 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.30230674 |
65 | TP63_23658742_ChIP-Seq_EP156T_Human | 1.29966817 |
66 | UTX_26944678_Chip-Seq_JUKART_Human | 1.29857397 |
67 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.29352240 |
68 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.29224675 |
69 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.28901725 |
70 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.28021349 |
71 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.26652669 |
72 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.26399602 |
73 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.25147645 |
74 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.25035905 |
75 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.24892674 |
76 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.24813349 |
77 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.23818417 |
78 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.23675410 |
79 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.23453797 |
80 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.23404338 |
81 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.23110203 |
82 | MYC_22102868_ChIP-Seq_BL_Human | 1.22439161 |
83 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.22182281 |
84 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.21861103 |
85 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.21761550 |
86 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.17015423 |
87 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.16202320 |
88 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.16039637 |
89 | * ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.15563955 |
90 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.14749686 |
91 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.14101663 |
92 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.13526413 |
93 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.11541427 |
94 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.11520642 |
95 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.11428399 |
96 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.11420578 |
97 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.11077093 |
98 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.10794169 |
99 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.10786881 |
100 | TP53_16413492_ChIP-PET_HCT116_Human | 1.09332030 |
101 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.07303958 |
102 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.06415469 |
103 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.05773579 |
104 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.05657823 |
105 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.04795167 |
106 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.04677569 |
107 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.04067979 |
108 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.03176308 |
109 | MAF_26560356_Chip-Seq_TH2_Human | 1.03081880 |
110 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.02201322 |
111 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.01503037 |
112 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.01464941 |
113 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.01441837 |
114 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.01316758 |
115 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.01311252 |
116 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.00723676 |
117 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.00651476 |
118 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.00551680 |
119 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.99171506 |
120 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.98825064 |
121 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.98380553 |
122 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.98003689 |
123 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.97201706 |
124 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.96940223 |
125 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.96040260 |
126 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.95669425 |
127 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.95433640 |
128 | VDR_22108803_ChIP-Seq_LS180_Human | 0.95185184 |
129 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.94830068 |
130 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.93709288 |
131 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.93686253 |
132 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.93426163 |
133 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.92899636 |
134 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.92660328 |
135 | GATA3_26560356_Chip-Seq_TH2_Human | 0.91089327 |
136 | ATF3_27146783_Chip-Seq_COLON_Human | 0.90591771 |
137 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.88758047 |
138 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.87905200 |
139 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.86620642 |
140 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.86602871 |
141 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.86347888 |
142 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.85473577 |
143 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.85421867 |
144 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.85052192 |
145 | KLF5_25053715_ChIP-Seq_YYC3_Human | 0.83635898 |
146 | * BCAT_22108803_ChIP-Seq_LS180_Human | 0.82793660 |
147 | * TCF4_22108803_ChIP-Seq_LS180_Human | 0.82539469 |
148 | * ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.82336817 |
149 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.82165435 |
150 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.81650476 |
151 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.80178313 |
152 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.79284773 |
153 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.77435041 |
154 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.77214211 |
155 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.77110109 |
156 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.75910820 |
157 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.74640676 |
158 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.73895107 |
159 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.73834626 |
160 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.73610197 |
161 | * PU_27001747_Chip-Seq_BMDM_Mouse | 0.72386673 |
162 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.72208875 |
163 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.70607288 |
164 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.70154428 |
165 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.70154428 |
166 | GATA1_22025678_ChIP-Seq_K562_Human | 0.68634729 |
167 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.68422933 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002796_impaired_skin_barrier | 5.58609833 |
2 | MP0002254_reproductive_system_inflammat | 5.24594555 |
3 | MP0005275_abnormal_skin_tensile | 4.51815060 |
4 | MP0003941_abnormal_skin_development | 3.81828113 |
5 | MP0010234_abnormal_vibrissa_follicle | 3.29099037 |
6 | MP0005501_abnormal_skin_physiology | 3.16769156 |
7 | MP0005451_abnormal_body_composition | 3.07616802 |
8 | MP0002060_abnormal_skin_morphology | 3.07143673 |
9 | MP0004947_skin_inflammation | 2.81243560 |
10 | MP0003705_abnormal_hypodermis_morpholog | 2.59514300 |
11 | MP0001216_abnormal_epidermal_layer | 2.58766121 |
12 | MP0003191_abnormal_cellular_cholesterol | 2.46147727 |
13 | MP0000383_abnormal_hair_follicle | 2.43400083 |
14 | MP0003453_abnormal_keratinocyte_physiol | 2.39283762 |
15 | MP0010771_integument_phenotype | 2.28785710 |
16 | MP0010678_abnormal_skin_adnexa | 2.25249023 |
17 | MP0000579_abnormal_nail_morphology | 2.23742212 |
18 | MP0004381_abnormal_hair_follicle | 2.19037236 |
19 | MP0003172_abnormal_lysosome_physiology | 2.14792892 |
20 | MP0001835_abnormal_antigen_presentation | 2.10951485 |
21 | MP0001346_abnormal_lacrimal_gland | 2.05536366 |
22 | MP0003436_decreased_susceptibility_to | 2.00436403 |
23 | MP0002098_abnormal_vibrissa_morphology | 1.89234126 |
24 | MP0002148_abnormal_hypersensitivity_rea | 1.87763982 |
25 | MP0006054_spinal_hemorrhage | 1.84065455 |
26 | MP0000858_altered_metastatic_potential | 1.81912868 |
27 | MP0000647_abnormal_sebaceous_gland | 1.80546879 |
28 | MP0000427_abnormal_hair_cycle | 1.76286725 |
29 | MP0003566_abnormal_cell_adhesion | 1.73132679 |
30 | MP0004782_abnormal_surfactant_physiolog | 1.68649688 |
31 | MP0000377_abnormal_hair_follicle | 1.56184474 |
32 | MP0001191_abnormal_skin_condition | 1.49801420 |
33 | MP0002419_abnormal_innate_immunity | 1.48174661 |
34 | MP0003091_abnormal_cell_migration | 1.48063192 |
35 | MP0008260_abnormal_autophagy | 1.46987915 |
36 | MP0001851_eye_inflammation | 1.46881912 |
37 | MP0008438_abnormal_cutaneous_collagen | 1.46556440 |
38 | MP0005164_abnormal_response_to | 1.46539170 |
39 | MP0003724_increased_susceptibility_to | 1.46496584 |
40 | MP0008004_abnormal_stomach_pH | 1.39736480 |
41 | MP0009931_abnormal_skin_appearance | 1.37049263 |
42 | MP0002877_abnormal_melanocyte_morpholog | 1.34961236 |
43 | MP0009333_abnormal_splenocyte_physiolog | 1.33491810 |
44 | MP0009278_abnormal_bone_marrow | 1.33117113 |
45 | MP0005397_hematopoietic_system_phenotyp | 1.31535854 |
46 | MP0001545_abnormal_hematopoietic_system | 1.31535854 |
47 | MP0009840_abnormal_foam_cell | 1.29076767 |
48 | MP0001533_abnormal_skeleton_physiology | 1.27961340 |
49 | MP0004185_abnormal_adipocyte_glucose | 1.26402676 |
50 | MP0005000_abnormal_immune_tolerance | 1.26373375 |
51 | MP0005025_abnormal_response_to | 1.26336987 |
52 | MP0000716_abnormal_immune_system | 1.26258710 |
53 | MP0000685_abnormal_immune_system | 1.25072785 |
54 | MP0003763_abnormal_thymus_physiology | 1.23288972 |
55 | MP0003950_abnormal_plasma_membrane | 1.23021678 |
56 | MP0009764_decreased_sensitivity_to | 1.21618688 |
57 | MP0010352_gastrointestinal_tract_polyps | 1.21454880 |
58 | MP0001243_abnormal_dermal_layer | 1.21177342 |
59 | MP0000566_synostosis | 1.20904029 |
60 | MP0005058_abnormal_lysosome_morphology | 1.19466121 |
61 | MP0009785_altered_susceptibility_to | 1.18889545 |
62 | MP0003656_abnormal_erythrocyte_physiolo | 1.14402097 |
63 | MP0002398_abnormal_bone_marrow | 1.12623596 |
64 | MP0000467_abnormal_esophagus_morphology | 1.11776842 |
65 | MP0002277_abnormal_respiratory_mucosa | 1.11075077 |
66 | MP0004883_abnormal_blood_vessel | 1.11003294 |
67 | MP0006082_CNS_inflammation | 1.08842956 |
68 | MP0003806_abnormal_nucleotide_metabolis | 1.07354287 |
69 | MP0005387_immune_system_phenotype | 1.07136999 |
70 | MP0001790_abnormal_immune_system | 1.07136999 |
71 | MP0002332_abnormal_exercise_endurance | 1.06999157 |
72 | MP0005257_abnormal_intraocular_pressure | 1.06452697 |
73 | MP0000367_abnormal_coat/_hair | 1.03321042 |
74 | MP0000465_gastrointestinal_hemorrhage | 1.01314087 |
75 | MP0001958_emphysema | 1.01127898 |
76 | MP0003828_pulmonary_edema | 1.00976076 |
77 | MP0004019_abnormal_vitamin_homeostasis | 1.00706338 |
78 | MP0000762_abnormal_tongue_morphology | 1.00275752 |
79 | MP0005165_increased_susceptibility_to | 0.99891256 |
80 | MP0002452_abnormal_antigen_presenting | 0.99802135 |
81 | MP0001853_heart_inflammation | 0.99718177 |
82 | MP0002429_abnormal_blood_cell | 0.98979825 |
83 | MP0003075_altered_response_to | 0.98439422 |
84 | MP0009763_increased_sensitivity_to | 0.96369710 |
85 | MP0002998_abnormal_bone_remodeling | 0.96299284 |
86 | MP0002009_preneoplasia | 0.94729985 |
87 | MP0005464_abnormal_platelet_physiology | 0.92548401 |
88 | MP0005023_abnormal_wound_healing | 0.92003640 |
89 | MP0000689_abnormal_spleen_morphology | 0.91032416 |
90 | MP0002722_abnormal_immune_system | 0.90988197 |
91 | MP0009384_cardiac_valve_regurgitation | 0.90864980 |
92 | MP0002139_abnormal_hepatobiliary_system | 0.88580356 |
93 | MP0005390_skeleton_phenotype | 0.87790919 |
94 | MP0001800_abnormal_humoral_immune | 0.86880667 |
95 | MP0004510_myositis | 0.86637322 |
96 | MP0002138_abnormal_hepatobiliary_system | 0.85281590 |
97 | MP0000249_abnormal_blood_vessel | 0.85191910 |
98 | MP0000604_amyloidosis | 0.85031220 |
99 | MP0004808_abnormal_hematopoietic_stem | 0.84195446 |
100 | MP0002723_abnormal_immune_serum | 0.83141539 |
101 | MP0001873_stomach_inflammation | 0.81732770 |
102 | MP0001845_abnormal_inflammatory_respons | 0.81179994 |
103 | MP0000343_altered_response_to | 0.79794820 |
104 | MP0001542_abnormal_bone_strength | 0.78696535 |
105 | MP0003448_altered_tumor_morphology | 0.78532570 |
106 | MP0010155_abnormal_intestine_physiology | 0.77733021 |
107 | MP0000767_abnormal_smooth_muscle | 0.75166963 |
108 | MP0003303_peritoneal_inflammation | 0.75128477 |
109 | MP0005647_abnormal_sex_gland | 0.74528163 |
110 | MP0002405_respiratory_system_inflammati | 0.73864138 |
111 | MP0000538_abnormal_urinary_bladder | 0.73697460 |
112 | MP0002933_joint_inflammation | 0.72326358 |
113 | MP0005167_abnormal_blood-brain_barrier | 0.71144550 |
114 | MP0002006_tumorigenesis | 0.70466640 |
115 | MP0003690_abnormal_glial_cell | 0.69555566 |
116 | MP0002166_altered_tumor_susceptibility | 0.68635071 |
117 | MP0000569_abnormal_digit_pigmentation | 0.68625130 |
118 | MP0002420_abnormal_adaptive_immunity | 0.68280226 |
119 | MP0001819_abnormal_immune_cell | 0.68243294 |
120 | MP0003300_gastrointestinal_ulcer | 0.67898962 |
121 | MP0003195_calcinosis | 0.67852222 |
122 | MP0009765_abnormal_xenobiotic_induced | 0.67506342 |
123 | MP0001340_abnormal_eyelid_morphology | 0.66035916 |
124 | MP0002876_abnormal_thyroid_physiology | 0.65753236 |
125 | MP0003279_aneurysm | 0.65737733 |
126 | MP0005310_abnormal_salivary_gland | 0.65047426 |
127 | MP0008469_abnormal_protein_level | 0.62067629 |
128 | MP0003045_fibrosis | 0.61434646 |
129 | MP0009379_abnormal_foot_pigmentation | 0.60356655 |
130 | MP0004272_abnormal_basement_membrane | 0.59650685 |
131 | MP0005166_decreased_susceptibility_to | 0.58752154 |
132 | MP0003795_abnormal_bone_structure | 0.57409261 |
133 | MP0005671_abnormal_response_to | 0.57004695 |
134 | MP0003183_abnormal_peptide_metabolism | 0.55294373 |
135 | MP0000627_abnormal_mammary_gland | 0.55236907 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Eczematoid dermatitis (HP:0000976) | 6.52522813 |
2 | Abnormality of liposaccharide metabolism (HP:0010968) | 5.03560138 |
3 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 5.03560138 |
4 | Abnormality of glycolipid metabolism (HP:0010969) | 5.03560138 |
5 | Increased IgE level (HP:0003212) | 4.81285806 |
6 | Systemic lupus erythematosus (HP:0002725) | 4.69733928 |
7 | Congenital ichthyosiform erythroderma (HP:0007431) | 4.60753514 |
8 | Plantar hyperkeratosis (HP:0007556) | 4.45295354 |
9 | Onycholysis (HP:0001806) | 4.30063929 |
10 | Thick nail (HP:0001805) | 4.20209812 |
11 | Hypotrichosis (HP:0001006) | 4.01766596 |
12 | Fragile nails (HP:0001808) | 3.99198311 |
13 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 3.99127998 |
14 | Right ventricular cardiomyopathy (HP:0011663) | 3.89615252 |
15 | Palmoplantar hyperkeratosis (HP:0000972) | 3.79611341 |
16 | Abnormality of nail color (HP:0100643) | 3.78974235 |
17 | Recurrent abscess formation (HP:0002722) | 3.69853633 |
18 | Gangrene (HP:0100758) | 3.68000677 |
19 | Lip pit (HP:0100267) | 3.66925420 |
20 | Recurrent bacterial skin infections (HP:0005406) | 3.61146617 |
21 | Palmar hyperkeratosis (HP:0010765) | 3.55561376 |
22 | Parakeratosis (HP:0001036) | 3.51266715 |
23 | Prostate neoplasm (HP:0100787) | 3.49571934 |
24 | Milia (HP:0001056) | 3.45921878 |
25 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.37200598 |
26 | Erythema (HP:0010783) | 3.34756891 |
27 | Erythroderma (HP:0001019) | 3.31567937 |
28 | Loss of speech (HP:0002371) | 3.29679934 |
29 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.27725005 |
30 | Ectropion (HP:0000656) | 3.27279182 |
31 | Woolly hair (HP:0002224) | 3.20764168 |
32 | Distal lower limb muscle weakness (HP:0009053) | 3.15665667 |
33 | Optic neuritis (HP:0100653) | 3.11898691 |
34 | Retrobulbar optic neuritis (HP:0100654) | 3.11898691 |
35 | Alopecia of scalp (HP:0002293) | 3.08359510 |
36 | Corneal erosion (HP:0200020) | 3.04773760 |
37 | Glomerulonephritis (HP:0000099) | 2.95676681 |
38 | Atrophic scars (HP:0001075) | 2.94899276 |
39 | Stomatitis (HP:0010280) | 2.88081536 |
40 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.86757101 |
41 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.86757101 |
42 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.86757101 |
43 | Spondylolisthesis (HP:0003302) | 2.85643556 |
44 | Abnormality of complement system (HP:0005339) | 2.84481316 |
45 | Mucopolysacchariduria (HP:0008155) | 2.78194123 |
46 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.78194123 |
47 | Pruritus (HP:0000989) | 2.74311385 |
48 | Aplasia cutis congenita (HP:0001057) | 2.73568246 |
49 | Increased cerebral lipofuscin (HP:0011813) | 2.71417461 |
50 | Xerostomia (HP:0000217) | 2.66345611 |
51 | Nail dystrophy (HP:0008404) | 2.62594468 |
52 | Autoimmune thrombocytopenia (HP:0001973) | 2.61259890 |
53 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.60919751 |
54 | Vasculitis (HP:0002633) | 2.53448073 |
55 | Congenital malformation of the right heart (HP:0011723) | 2.53280752 |
56 | Double outlet right ventricle (HP:0001719) | 2.53280752 |
57 | Natal tooth (HP:0000695) | 2.52901219 |
58 | Vacuolated lymphocytes (HP:0001922) | 2.51394747 |
59 | Abnormality of macrophages (HP:0004311) | 2.50964528 |
60 | Complement deficiency (HP:0004431) | 2.48067834 |
61 | Abnormal blistering of the skin (HP:0008066) | 2.47577324 |
62 | Nephritis (HP:0000123) | 2.43001492 |
63 | Vertebral compression fractures (HP:0002953) | 2.42493223 |
64 | Hemoptysis (HP:0002105) | 2.42248329 |
65 | Hypohidrosis (HP:0000966) | 2.42135900 |
66 | Pustule (HP:0200039) | 2.41877859 |
67 | Urticaria (HP:0001025) | 2.40532962 |
68 | Recurrent skin infections (HP:0001581) | 2.39915033 |
69 | Abnormality of the axillary hair (HP:0100134) | 2.35240179 |
70 | Abnormality of secondary sexual hair (HP:0009888) | 2.35240179 |
71 | Recurrent viral infections (HP:0004429) | 2.34176824 |
72 | Keratoconjunctivitis sicca (HP:0001097) | 2.33670497 |
73 | Osteolytic defects of the hand bones (HP:0009699) | 2.30497489 |
74 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.30497489 |
75 | Disinhibition (HP:0000734) | 2.27607026 |
76 | Abnormality of proline metabolism (HP:0010907) | 2.27161511 |
77 | Hydroxyprolinuria (HP:0003080) | 2.27161511 |
78 | Meningitis (HP:0001287) | 2.26781101 |
79 | Axonal loss (HP:0003447) | 2.26665052 |
80 | Advanced eruption of teeth (HP:0006288) | 2.26476684 |
81 | Neurofibrillary tangles (HP:0002185) | 2.26277778 |
82 | Spontaneous hematomas (HP:0007420) | 2.23154195 |
83 | Myocardial infarction (HP:0001658) | 2.21640140 |
84 | Amyloidosis (HP:0011034) | 2.21508912 |
85 | Thrombocytosis (HP:0001894) | 2.21073692 |
86 | Mediastinal lymphadenopathy (HP:0100721) | 2.20518633 |
87 | Acanthosis nigricans (HP:0000956) | 2.19406821 |
88 | Hematochezia (HP:0002573) | 2.18357615 |
89 | Orchitis (HP:0100796) | 2.16776408 |
90 | Conical tooth (HP:0000698) | 2.16362216 |
91 | Hypergammaglobulinemia (HP:0010702) | 2.15143922 |
92 | Gingivitis (HP:0000230) | 2.15102326 |
93 | Hyporeflexia of lower limbs (HP:0002600) | 2.13303833 |
94 | Joint hemorrhage (HP:0005261) | 2.13284406 |
95 | Peritonitis (HP:0002586) | 2.12850925 |
96 | Premature loss of primary teeth (HP:0006323) | 2.11212427 |
97 | Hepatosplenomegaly (HP:0001433) | 2.10853449 |
98 | Keratoconjunctivitis (HP:0001096) | 2.10609245 |
99 | Increased serum ferritin (HP:0003281) | 2.09391086 |
100 | Petechiae (HP:0000967) | 2.09185463 |
101 | Gastrointestinal infarctions (HP:0005244) | 2.05792757 |
102 | Cellulitis (HP:0100658) | 2.05609299 |
103 | Chest pain (HP:0100749) | 2.03579797 |
104 | Gingival bleeding (HP:0000225) | 2.02650054 |
105 | Xanthomatosis (HP:0000991) | 2.02111622 |
106 | Sepsis (HP:0100806) | 2.00756159 |
107 | Anhidrosis (HP:0000970) | 1.99848346 |
108 | Epistaxis (HP:0000421) | 1.99639212 |
109 | Nuclear cataract (HP:0100018) | 1.97974016 |
110 | Abnormality of the pericardium (HP:0001697) | 1.97862141 |
111 | Arterial thrombosis (HP:0004420) | 1.96937354 |
112 | T lymphocytopenia (HP:0005403) | 1.95877888 |
113 | Leukocytosis (HP:0001974) | 1.94664007 |
114 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.94088912 |
115 | Glomerulopathy (HP:0100820) | 1.93475256 |
116 | Periodontitis (HP:0000704) | 1.92590316 |
117 | Mutism (HP:0002300) | 1.92364115 |
118 | Polyneuropathy (HP:0001271) | 1.92030734 |
119 | Purpura (HP:0000979) | 1.91995995 |
120 | Progressive neurologic deterioration (HP:0002344) | 1.89806877 |
121 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.89390407 |
122 | Skin ulcer (HP:0200042) | 1.89291854 |
123 | Upper limb muscle weakness (HP:0003484) | 1.88743278 |
124 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.88130124 |
125 | Tetraparesis (HP:0002273) | 1.87471978 |
126 | Asymmetric septal hypertrophy (HP:0001670) | 1.87094023 |
127 | Myositis (HP:0100614) | 1.86914424 |
128 | Abnormality of T cell number (HP:0011839) | 1.86599854 |
129 | Interstitial pulmonary disease (HP:0006530) | 1.86517602 |
130 | Fragile skin (HP:0001030) | 1.86216414 |
131 | Chronic obstructive pulmonary disease (HP:0006510) | 1.85929638 |
132 | Obstructive lung disease (HP:0006536) | 1.85929638 |
133 | Recurrent cutaneous fungal infections (HP:0011370) | 1.85001575 |
134 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.85001575 |
135 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.84938774 |
136 | Basal ganglia calcification (HP:0002135) | 1.83412394 |
137 | Palmoplantar keratoderma (HP:0000982) | 1.83351490 |
138 | Apathy (HP:0000741) | 1.82740623 |
139 | Autoimmune hemolytic anemia (HP:0001890) | 1.82709706 |
140 | Bone pain (HP:0002653) | 1.82408118 |
141 | Fatigue (HP:0012378) | 1.82168260 |
142 | Diminished motivation (HP:0000745) | 1.81653124 |
143 | Recurrent corneal erosions (HP:0000495) | 1.81551294 |
144 | Recurrent fungal infections (HP:0002841) | 1.80561503 |
145 | Corneal dystrophy (HP:0001131) | 1.79149019 |
146 | Premature rupture of membranes (HP:0001788) | 1.79097155 |
147 | Sparse scalp hair (HP:0002209) | 1.76462271 |
148 | Abnormality of the nasal septum (HP:0000419) | 1.74980823 |
149 | Pulmonary infiltrates (HP:0002113) | 1.74228550 |
150 | Curly hair (HP:0002212) | 1.73403550 |
151 | Dysostosis multiplex (HP:0000943) | 1.72662987 |
152 | Malignant hyperthermia (HP:0002047) | 1.71653464 |
153 | Lack of skin elasticity (HP:0100679) | 1.71500989 |
154 | Ventricular tachycardia (HP:0004756) | 1.71487084 |
155 | Hypoplasia of dental enamel (HP:0006297) | 1.71470880 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MST1R | 4.47408167 |
2 | MAP3K14 | 3.44826362 |
3 | BLK | 2.91704917 |
4 | PRPF4B | 2.43021049 |
5 | TGFBR2 | 2.36845225 |
6 | TYK2 | 2.36097306 |
7 | MAPKAPK3 | 2.34132061 |
8 | TRPM7 | 2.29997538 |
9 | ERN1 | 2.14665655 |
10 | RIPK4 | 2.14514075 |
11 | EPHA3 | 2.10001837 |
12 | MAP2K3 | 2.08554450 |
13 | NME2 | 2.01206535 |
14 | CSK | 1.97084088 |
15 | MET | 1.96564729 |
16 | MAP4K1 | 1.85163023 |
17 | EPHB2 | 1.83173608 |
18 | MAP3K3 | 1.83115484 |
19 | IRAK4 | 1.82874062 |
20 | ZAP70 | 1.82669470 |
21 | BMPR2 | 1.82122766 |
22 | IKBKE | 1.77634345 |
23 | PIK3CG | 1.75562847 |
24 | ERBB3 | 1.71322203 |
25 | FER | 1.70196697 |
26 | TBK1 | 1.70145274 |
27 | MST4 | 1.69068477 |
28 | MAP3K13 | 1.64670694 |
29 | PIM2 | 1.64417224 |
30 | IRAK3 | 1.64123338 |
31 | GRK7 | 1.59201915 |
32 | IKBKB | 1.57692282 |
33 | SIK3 | 1.53133673 |
34 | LATS1 | 1.50950705 |
35 | TAOK1 | 1.40457114 |
36 | TEC | 1.39324273 |
37 | SIK1 | 1.36033894 |
38 | STK10 | 1.34424996 |
39 | BMPR1B | 1.26862772 |
40 | LRRK2 | 1.25448610 |
41 | ARAF | 1.23957257 |
42 | PTK6 | 1.23793785 |
43 | FES | 1.23660926 |
44 | BMX | 1.22825849 |
45 | CASK | 1.15997253 |
46 | MOS | 1.15732141 |
47 | EIF2AK2 | 1.14269253 |
48 | PAK4 | 1.08726025 |
49 | RPS6KA4 | 1.07046246 |
50 | TESK2 | 1.05954286 |
51 | TESK1 | 1.05503011 |
52 | HCK | 1.02590729 |
53 | EPHB1 | 1.02214681 |
54 | JAK1 | 1.02075097 |
55 | CDC42BPA | 1.01684866 |
56 | FGFR4 | 0.98414875 |
57 | GRK5 | 0.95482593 |
58 | MAP3K2 | 0.94018718 |
59 | MAPKAPK5 | 0.93831475 |
60 | RIPK1 | 0.93238586 |
61 | NLK | 0.90667681 |
62 | KIT | 0.90213164 |
63 | CHUK | 0.89989410 |
64 | INSRR | 0.88464453 |
65 | PBK | 0.87976485 |
66 | MYLK | 0.85330219 |
67 | MAP3K5 | 0.85170374 |
68 | PDGFRA | 0.84452328 |
69 | JAK3 | 0.84105316 |
70 | ITK | 0.83065435 |
71 | MAP3K11 | 0.82179358 |
72 | JAK2 | 0.80377539 |
73 | TTN | 0.80254169 |
74 | FRK | 0.77576032 |
75 | BTK | 0.76800883 |
76 | IRAK1 | 0.76125367 |
77 | MAP3K1 | 0.75950787 |
78 | MAP3K12 | 0.74851972 |
79 | FGFR1 | 0.74825085 |
80 | IRAK2 | 0.73094063 |
81 | SYK | 0.70939053 |
82 | FGFR3 | 0.68454615 |
83 | PDGFRB | 0.65539266 |
84 | PRKD2 | 0.64500714 |
85 | MAP2K1 | 0.64431765 |
86 | MAPKAPK2 | 0.63583733 |
87 | MAP2K2 | 0.59336371 |
88 | FGR | 0.59228555 |
89 | STK24 | 0.58367723 |
90 | TAOK3 | 0.58294932 |
91 | CDK8 | 0.56888813 |
92 | MAPK12 | 0.56801968 |
93 | MAP3K6 | 0.54714551 |
94 | CDK6 | 0.54537104 |
95 | FLT3 | 0.54509208 |
96 | NEK9 | 0.53918449 |
97 | ERBB4 | 0.53681681 |
98 | CDK19 | 0.53590797 |
99 | MAPK7 | 0.52018976 |
100 | KSR2 | 0.51988176 |
101 | PRKCD | 0.51581188 |
102 | CSF1R | 0.50045662 |
103 | PRKCE | 0.50032932 |
104 | LIMK1 | 0.49426284 |
105 | GRK6 | 0.49396819 |
106 | PDPK1 | 0.49013934 |
107 | LYN | 0.47380409 |
108 | TGFBR1 | 0.46243072 |
109 | DAPK2 | 0.45922584 |
110 | MAP3K8 | 0.45833077 |
111 | IGF1R | 0.44887730 |
112 | DYRK1B | 0.44246639 |
113 | STK3 | 0.43931585 |
114 | MATK | 0.43774753 |
115 | EGFR | 0.43351167 |
116 | PDK1 | 0.43132261 |
117 | CDK3 | 0.43009062 |
118 | MARK3 | 0.42694051 |
119 | EIF2AK3 | 0.42632471 |
120 | GRK1 | 0.42506526 |
121 | ABL2 | 0.41522395 |
122 | ABL1 | 0.39825303 |
123 | PAK2 | 0.39725536 |
124 | SIK2 | 0.39643049 |
125 | TAOK2 | 0.39283310 |
126 | PTK2 | 0.39031326 |
127 | LCK | 0.37893000 |
128 | MAPK4 | 0.36115265 |
129 | NTRK1 | 0.35715949 |
130 | TXK | 0.35142063 |
131 | TRIB3 | 0.34841194 |
132 | PTK2B | 0.34709112 |
133 | ADRBK2 | 0.34050030 |
134 | DDR2 | 0.33191598 |
135 | CAMK1D | 0.33046043 |
136 | CLK1 | 0.32898352 |
137 | GSK3A | 0.32419513 |
138 | EPHA2 | 0.31611791 |
139 | HIPK2 | 0.30551864 |
140 | INSR | 0.30338202 |
141 | RPS6KC1 | 0.29146489 |
142 | RPS6KL1 | 0.29146489 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.92826380 |
2 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.32421163 |
3 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.26501588 |
4 | Pertussis_Homo sapiens_hsa05133 | 2.17040246 |
5 | Leishmaniasis_Homo sapiens_hsa05140 | 2.11993406 |
6 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.04572649 |
7 | Malaria_Homo sapiens_hsa05144 | 1.98731100 |
8 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.92287179 |
9 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.85220172 |
10 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.77170985 |
11 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.76381416 |
12 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.71885059 |
13 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.71573959 |
14 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.69588755 |
15 | Lysosome_Homo sapiens_hsa04142 | 1.65587649 |
16 | Viral myocarditis_Homo sapiens_hsa05416 | 1.60867937 |
17 | Tuberculosis_Homo sapiens_hsa05152 | 1.60422057 |
18 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.55597451 |
19 | Histidine metabolism_Homo sapiens_hsa00340 | 1.55305564 |
20 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.51959619 |
21 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.51673958 |
22 | Phagosome_Homo sapiens_hsa04145 | 1.51511843 |
23 | Amoebiasis_Homo sapiens_hsa05146 | 1.49175771 |
24 | Legionellosis_Homo sapiens_hsa05134 | 1.45703005 |
25 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.45696046 |
26 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.45147113 |
27 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.43788102 |
28 | Other glycan degradation_Homo sapiens_hsa00511 | 1.35785662 |
29 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.30599187 |
30 | ABC transporters_Homo sapiens_hsa02010 | 1.28256162 |
31 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.20053036 |
32 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.19956804 |
33 | Asthma_Homo sapiens_hsa05310 | 1.17400774 |
34 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.17353891 |
35 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.16782419 |
36 | Retinol metabolism_Homo sapiens_hsa00830 | 1.16531881 |
37 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.15458352 |
38 | Hepatitis B_Homo sapiens_hsa05161 | 1.14480547 |
39 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.13638403 |
40 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.12265809 |
41 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.12183051 |
42 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.09936511 |
43 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.08265195 |
44 | Bladder cancer_Homo sapiens_hsa05219 | 1.07295050 |
45 | Salmonella infection_Homo sapiens_hsa05132 | 1.05821131 |
46 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.03851055 |
47 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.02596259 |
48 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.00759565 |
49 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.00468989 |
50 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.99307406 |
51 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.99116467 |
52 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.96691249 |
53 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.95470795 |
54 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.95354444 |
55 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.94238235 |
56 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.92852307 |
57 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.92695078 |
58 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.89375728 |
59 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.88327116 |
60 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.86917782 |
61 | Prion diseases_Homo sapiens_hsa05020 | 0.86884766 |
62 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.86748463 |
63 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.85472455 |
64 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.85462099 |
65 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.82604984 |
66 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.81716900 |
67 | Hepatitis C_Homo sapiens_hsa05160 | 0.79506454 |
68 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.79353418 |
69 | Melanoma_Homo sapiens_hsa05218 | 0.79141763 |
70 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.78203660 |
71 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.76587027 |
72 | Apoptosis_Homo sapiens_hsa04210 | 0.74641204 |
73 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.74164464 |
74 | Measles_Homo sapiens_hsa05162 | 0.73420128 |
75 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.73408803 |
76 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.73269314 |
77 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.73247556 |
78 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.72125056 |
79 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.71127748 |
80 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.71110100 |
81 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.69158061 |
82 | Influenza A_Homo sapiens_hsa05164 | 0.67370043 |
83 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.66976168 |
84 | Platelet activation_Homo sapiens_hsa04611 | 0.66370142 |
85 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.65738315 |
86 | Adherens junction_Homo sapiens_hsa04520 | 0.64372161 |
87 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.64246421 |
88 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.62337982 |
89 | Mineral absorption_Homo sapiens_hsa04978 | 0.61793747 |
90 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.58441143 |
91 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.57539343 |
92 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.57429782 |
93 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.57295346 |
94 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.56930773 |
95 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.55595002 |
96 | HTLV-I infection_Homo sapiens_hsa05166 | 0.54372644 |
97 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.54334845 |
98 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.54051959 |
99 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.52976409 |
100 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.50010002 |
101 | Peroxisome_Homo sapiens_hsa04146 | 0.48305379 |
102 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.47788357 |
103 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.47324077 |
104 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.46945571 |
105 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.46879881 |
106 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.46778108 |
107 | Focal adhesion_Homo sapiens_hsa04510 | 0.46421378 |
108 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.45968326 |
109 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.45862186 |
110 | Allograft rejection_Homo sapiens_hsa05330 | 0.45511627 |
111 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.44423624 |
112 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.44046905 |
113 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.43484566 |
114 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.43198261 |
115 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.42577500 |
116 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.42328493 |
117 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.41732048 |
118 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.40956364 |
119 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.40558859 |
120 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.40366475 |
121 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.40345135 |
122 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.39770648 |
123 | Shigellosis_Homo sapiens_hsa05131 | 0.39168993 |
124 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.38159920 |
125 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.37978260 |
126 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.37533035 |
127 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.35511131 |
128 | Galactose metabolism_Homo sapiens_hsa00052 | 0.35364789 |
129 | Endocytosis_Homo sapiens_hsa04144 | 0.34604522 |
130 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.34301570 |
131 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.33107653 |
132 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.31680520 |
133 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.29785897 |
134 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.29374335 |
135 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.28631523 |
136 | Prostate cancer_Homo sapiens_hsa05215 | 0.24879676 |
137 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.24262039 |
138 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.24219209 |
139 | Insulin resistance_Homo sapiens_hsa04931 | 0.21856657 |